Search research articles
Contact Us
Filters
Showing results (711-720 of 962) with videos related to
Page
of 97
Sort By:
Journal of the American College of Cardiology
|
October 8, 2021
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT
Prakriti Gaba, Deepak L Bhatt, Robert P Giugliano, et al.
Circulation
|
October 28, 2021
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
Arjun Majithia, Deepak L Bhatt, Allon N Friedman, et al.
Circulation. Cardiovascular Interventions
|
September 19, 2023
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial
Zardasht Oqab, Vijay Kunadian, David A Wood, et al.
JAMA Cardiology
|
September 27, 2019
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial
Mariusz Tomaniak, Ply Chichareon, Yoshinobu Onuma, et al.
Lancet (London, England)
|
September 10, 2013
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
Philippe Gabriel Steg, Deepak L Bhatt, Christian W Hamm, et al.
Journal of the American College of Cardiology
|
April 28, 2022
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction
Prakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, et al.
The New England Journal of Medicine
|
May 22, 2009
Early versus delayed invasive intervention in acute coronary syndromes
Shamir R Mehta, Christopher B Granger, William E Boden, et al.
European Heart Journal
|
October 25, 2011
Antiplatelet agents for the treatment and prevention of atherothrombosis
Carlo Patrono, Felicita Andreotti, Harald Arnesen, et al.
Diabetes Care
|
January 2, 2015
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial
Jacob A Udell, Deepak L Bhatt, Eugene Braunwald, et al.
European Heart Journal
|
December 8, 2019
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
Remo H M Furtado, Jose C Nicolau, Giulia Magnani, et al.
Page
of 97
Search research articles
Search
Showing results (711-720 of 962) with videos related to
Sort By:
Page
of 97
Journal of the American College of Cardiology
|
October 8, 2021
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT
Prakriti Gaba, Deepak L Bhatt, Robert P Giugliano, et al.
Circulation
|
October 28, 2021
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
Arjun Majithia, Deepak L Bhatt, Allon N Friedman, et al.
Circulation. Cardiovascular Interventions
|
September 19, 2023
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial
Zardasht Oqab, Vijay Kunadian, David A Wood, et al.
JAMA Cardiology
|
September 27, 2019
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial
Mariusz Tomaniak, Ply Chichareon, Yoshinobu Onuma, et al.
Lancet (London, England)
|
September 10, 2013
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
Philippe Gabriel Steg, Deepak L Bhatt, Christian W Hamm, et al.
Journal of the American College of Cardiology
|
April 28, 2022
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction
Prakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, et al.
The New England Journal of Medicine
|
May 22, 2009
Early versus delayed invasive intervention in acute coronary syndromes
Shamir R Mehta, Christopher B Granger, William E Boden, et al.
European Heart Journal
|
October 25, 2011
Antiplatelet agents for the treatment and prevention of atherothrombosis
Carlo Patrono, Felicita Andreotti, Harald Arnesen, et al.
Diabetes Care
|
January 2, 2015
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial
Jacob A Udell, Deepak L Bhatt, Eugene Braunwald, et al.
European Heart Journal
|
December 8, 2019
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
Remo H M Furtado, Jose C Nicolau, Giulia Magnani, et al.
Page
of 97